[HTML][HTML] Liposomes: structure, biomedical applications, and stability parameters with emphasis on cholesterol
P Nakhaei, R Margiana, DO Bokov… - … in bioengineering and …, 2021 - ncbi.nlm.nih.gov
Liposomes are essentially a subtype of nanoparticles comprising a hydrophobic tail and a
hydrophilic head constituting a phospholipid membrane. The spherical or multilayered …
hydrophilic head constituting a phospholipid membrane. The spherical or multilayered …
[HTML][HTML] Recent advances in polysaccharides based biomaterials for drug delivery and tissue engineering applications
In this paper, a spotlight is shown on polysaccharides based biomaterials which have
surfaced as a versatile platform for different biomedical applications including drug delivery …
surfaced as a versatile platform for different biomedical applications including drug delivery …
[HTML][HTML] Functionalized liposomes for targeted breast cancer drug delivery
Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and
treatment strategies, it remains a prominent cause of female mortality worldwide …
treatment strategies, it remains a prominent cause of female mortality worldwide …
[HTML][HTML] Polymeric particle-based therapies for acute inflammatory diseases
ER Brannon, MV Guevara, NJ Pacifici, JK Lee… - Nature Reviews …, 2022 - nature.com
Acute inflammation is essential for initiating and coordinating the body's response to injuries
and infections. However, in acute inflammatory diseases, inflammation is not resolved but …
and infections. However, in acute inflammatory diseases, inflammation is not resolved but …
Targeted liposomal drug delivery: a nanoscience and biophysical perspective
Y Liu, KMC Bravo, J Liu - Nanoscale Horizons, 2021 - pubs.rsc.org
Liposomes are a unique platform for drug delivery, and a number of liposomal formulations
have already been commercialized. Doxil is a representative example, which uses …
have already been commercialized. Doxil is a representative example, which uses …
Walking dead tumor cells for targeted drug delivery against lung metastasis of triple‐negative breast cancer
Z Zhao, L Fang, P Xiao, X Sun, L Zhou, X Liu… - Advanced …, 2022 - Wiley Online Library
Lung metastasis is challenging in patients with triple‐negative breast cancer (TNBC).
Surgery is always not available due to the dissemination of metastatic foci and most drugs …
Surgery is always not available due to the dissemination of metastatic foci and most drugs …
[HTML][HTML] Liposomes in cancer therapy: how did we start and where are we now
MD Fulton, W Najahi-Missaoui - International Journal of Molecular …, 2023 - mdpi.com
Since their first discovery in the 1960s by Alec Bangham, liposomes have been shown to be
effective drug delivery systems for treating various cancers. Several liposome-based …
effective drug delivery systems for treating various cancers. Several liposome-based …
Exosomes as a next-generation drug delivery system: An update on drug loading approaches, characterization, and clinical application challenges
Exosomes are small nanoparticles secreted by almost all cells and have a well-known role
in intercellular communication. They are found in different body fluids and can also be …
in intercellular communication. They are found in different body fluids and can also be …
Immunogenic hybrid nanovesicles of liposomes and tumor-derived nanovesicles for cancer immunochemotherapy
M Hu, J Zhang, L Kong, Y Yu, Q Hu, T Yang, Y Wang… - Acs Nano, 2021 - ACS Publications
Exploring a rational delivery system of integrating chemotherapy with immunotherapy to
broaden benefits of cancer immunochemotherapy is still under challenge. Herein, we …
broaden benefits of cancer immunochemotherapy is still under challenge. Herein, we …
Temperature treatment of highly porous zirconium-containing metal–organic frameworks extends drug delivery release
Utilizing metal–organic frameworks (MOFs) as a biological carrier can lower the amount of
the active pharmaceutical ingredient (API) required in cancer treatments to provide a more …
the active pharmaceutical ingredient (API) required in cancer treatments to provide a more …